641 related articles for article (PubMed ID: 27349436)
1. The Role of the Microbial Metabolites Including Tryptophan Catabolites and Short Chain Fatty Acids in the Pathophysiology of Immune-Inflammatory and Neuroimmune Disease.
Morris G; Berk M; Carvalho A; Caso JR; Sanz Y; Walder K; Maes M
Mol Neurobiol; 2017 Aug; 54(6):4432-4451. PubMed ID: 27349436
[TBL] [Abstract][Full Text] [Related]
2. Impact of Bacterial Metabolites on Gut Barrier Function and Host Immunity: A Focus on Bacterial Metabolism and Its Relevance for Intestinal Inflammation.
Gasaly N; de Vos P; Hermoso MA
Front Immunol; 2021; 12():658354. PubMed ID: 34122415
[TBL] [Abstract][Full Text] [Related]
3. Immunomodulatory potential of gut microbiome-derived short-chain fatty acids (SCFAs).
Ratajczak W; Rył A; Mizerski A; Walczakiewicz K; Sipak O; Laszczyńska M
Acta Biochim Pol; 2019 Mar; 66(1):1-12. PubMed ID: 30831575
[TBL] [Abstract][Full Text] [Related]
4. Short-chain fatty acids: microbial metabolites that alleviate stress-induced brain-gut axis alterations.
van de Wouw M; Boehme M; Lyte JM; Wiley N; Strain C; O'Sullivan O; Clarke G; Stanton C; Dinan TG; Cryan JF
J Physiol; 2018 Oct; 596(20):4923-4944. PubMed ID: 30066368
[TBL] [Abstract][Full Text] [Related]
5. Gut-brain Axis: Role of Lipids in the Regulation of Inflammation, Pain and CNS Diseases.
Russo R; Cristiano C; Avagliano C; De Caro C; La Rana G; Raso GM; Canani RB; Meli R; Calignano A
Curr Med Chem; 2018; 25(32):3930-3952. PubMed ID: 28215162
[TBL] [Abstract][Full Text] [Related]
6. Microbial-Derived Tryptophan Catabolites, Kidney Disease and Gut Inflammation.
Madella AM; Van Bergenhenegouwen J; Garssen J; Masereeuw R; Overbeek SA
Toxins (Basel); 2022 Sep; 14(9):. PubMed ID: 36136583
[TBL] [Abstract][Full Text] [Related]
7. Impacts of microbiome metabolites on immune regulation and autoimmunity.
Haase S; Haghikia A; Wilck N; Müller DN; Linker RA
Immunology; 2018 Jun; 154(2):230-238. PubMed ID: 29637999
[TBL] [Abstract][Full Text] [Related]
8. Role of microbiota-derived short-chain fatty acids in nervous system disorders.
Mirzaei R; Bouzari B; Hosseini-Fard SR; Mazaheri M; Ahmadyousefi Y; Abdi M; Jalalifar S; Karimitabar Z; Teimoori A; Keyvani H; Zamani F; Yousefimashouf R; Karampoor S
Biomed Pharmacother; 2021 Jul; 139():111661. PubMed ID: 34243604
[TBL] [Abstract][Full Text] [Related]
9. Physiological Role of Gut Microbiota for Maintaining Human Health.
Andoh A
Digestion; 2016; 93(3):176-81. PubMed ID: 26859303
[TBL] [Abstract][Full Text] [Related]
10. Gut-Microbiota-Derived Metabolites Maintain Gut and Systemic Immune Homeostasis.
Wang J; Zhu N; Su X; Gao Y; Yang R
Cells; 2023 Mar; 12(5):. PubMed ID: 36899929
[TBL] [Abstract][Full Text] [Related]
11. Diabesity and mood disorders: Multiple links through the microbiota-gut-brain axis.
Farzi A; Hassan AM; Zenz G; Holzer P
Mol Aspects Med; 2019 Apr; 66():80-93. PubMed ID: 30513310
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiota-derived short-chain fatty acids and kidney diseases.
Li L; Ma L; Fu P
Drug Des Devel Ther; 2017; 11():3531-3542. PubMed ID: 29270002
[TBL] [Abstract][Full Text] [Related]
13. Effects of short chain fatty acids on metabolic and inflammatory processes in human health.
Campos-Perez W; Martinez-Lopez E
Biochim Biophys Acta Mol Cell Biol Lipids; 2021 May; 1866(5):158900. PubMed ID: 33571672
[TBL] [Abstract][Full Text] [Related]
14. Role of microbiota short-chain fatty acids in the pathogenesis of autoimmune diseases.
Rasouli-Saravani A; Jahankhani K; Moradi S; Gorgani M; Shafaghat Z; Mirsanei Z; Mehmandar A; Mirzaei R
Biomed Pharmacother; 2023 Jun; 162():114620. PubMed ID: 37004324
[TBL] [Abstract][Full Text] [Related]
15. The interplay among gut microbiota, hypertension and kidney diseases: The role of short-chain fatty acids.
Felizardo RJF; Watanabe IKM; Dardi P; Rossoni LV; Câmara NOS
Pharmacol Res; 2019 Mar; 141():366-377. PubMed ID: 30639376
[TBL] [Abstract][Full Text] [Related]
16. Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.
Rizzetto L; Fava F; Tuohy KM; Selmi C
J Autoimmun; 2018 Aug; 92():12-34. PubMed ID: 29861127
[TBL] [Abstract][Full Text] [Related]
17. A Cross-Talk Between Microbiota-Derived Short-Chain Fatty Acids and the Host Mucosal Immune System Regulates Intestinal Homeostasis and Inflammatory Bowel Disease.
Gonçalves P; Araújo JR; Di Santo JP
Inflamm Bowel Dis; 2018 Feb; 24(3):558-572. PubMed ID: 29462379
[TBL] [Abstract][Full Text] [Related]
18. Dietary SCFAs, IL-22, and GFAP: The Three Musketeers in the Gut-Neuro-Immune Network in Type 1 Diabetes.
Jayasimhan A; Mariño E
Front Immunol; 2019; 10():2429. PubMed ID: 31736937
[TBL] [Abstract][Full Text] [Related]
19. Microbiota-derived short-chain fatty acids and modulation of host-derived peptides formation: Focused on host defense peptides.
Liu T; Sun Z; Yang Z; Qiao X
Biomed Pharmacother; 2023 Jun; 162():114586. PubMed ID: 36989711
[TBL] [Abstract][Full Text] [Related]
20. Microbial metabolism of dietary components to bioactive metabolites: opportunities for new therapeutic interventions.
Zhang LS; Davies SS
Genome Med; 2016 Apr; 8(1):46. PubMed ID: 27102537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
